Cisen Pharmaceutical Co.,Ltd. — Investor Relations & Filings
About Cisen Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical Co.,Ltd. is a comprehensive enterprise dedicated to the research, development, production, and marketing of a diverse range of medicinal products. The company specializes in the manufacture of large-volume injections, small-volume injections, and solid oral dosage forms, including tablets and capsules. Its product portfolio addresses critical therapeutic areas such as parenteral nutrition, anti-infectives, cardiovascular health, and anesthesia. Cisen Pharmaceutical maintains an integrated value chain, producing both active pharmaceutical ingredients (APIs) and finished formulations. The organization emphasizes technological innovation and stringent quality management systems to ensure the efficacy and safety of its medical solutions. By leveraging advanced manufacturing capabilities and a robust distribution network, the company provides essential healthcare products to clinical institutions and medical providers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 辰欣药业股份有限公司关于股东股份解除质押的公告 | 2026-01-08 | Chinese | |
| 辰欣药业股份有限公司关于公司及控股子公司使用闲置自有资金进行委托理财及证券投资的公告 | 2026-01-05 | Chinese | |
| 辰欣药业股份有限公司第五届董事会第十一次会议决议公告 | 2026-01-05 | Chinese | |
| 第五届董事会第十一次会议决议【签字盖章】 | 2026-01-05 | Chinese | |
| 辰欣药业股份有限公司关于持股5%以上股东减持股份结果暨股东权益变动触及5%刻度的提示性公告 | 2025-11-26 | Chinese | |
| 简式权益变动报告书(韩延振) | 2025-11-26 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 37406631 | 辰欣药业股份有限公司关于股东股份解除质押的公告 | 2026-01-08 | Chinese | ||
| 37406620 | 辰欣药业股份有限公司关于公司及控股子公司使用闲置自有资金进行委托理财及证券投资的公告 | 2026-01-05 | Chinese | ||
| 37406606 | 辰欣药业股份有限公司第五届董事会第十一次会议决议公告 | 2026-01-05 | Chinese | ||
| 37406578 | 第五届董事会第十一次会议决议【签字盖章】 | 2026-01-05 | Chinese | ||
|
2025
11 filings
| |||||
| 37406334 | 辰欣药业股份有限公司关于持股5%以上股东减持股份结果暨股东权益变动触及5%刻度的提示性公告 | 2025-11-26 | Chinese | ||
| 37406325 | 简式权益变动报告书(韩延振) | 2025-11-26 | Chinese | ||
| 37406318 | 辰欣药业股份有限公司关于2025年第三季度业绩说明会召开情况的公告 | 2025-11-26 | Chinese | ||
| 37406303 | 辰欣药业股份有限公司关于持股5%以上股东及其一致行动人权益变动触及1%刻度的提示性公告 | 2025-11-25 | Chinese | ||
| 37406298 | 辰欣药业股份有限公司关于召开2025年第三季度业绩说明会的公告 | 2025-11-20 | Chinese | ||
| 37406290 | 辰欣药业股份有限公司关于持股5%以上股东的一致行动人变更名称、注册地址和经营范围的公告 | 2025-11-17 | Chinese | ||
| 37406282 | 辰欣药业股份有限公司信息披露暂缓与豁免管理制度(2025年10月) | 2025-10-28 | Chinese | ||
| 37406273 | 辰欣药业股份有限公司关于补选公司第五届董事会薪酬与考核委员会委员的公告 | 2025-10-28 | Chinese | ||
| 37406264 | 辰欣药业股份有限公司2025年第三季度报告 | 2025-10-28 | Chinese | ||
| 37406262 | 辰欣药业股份有限公司关于制定及修订公司治理相关制度的公告 | 2025-10-28 | Chinese | ||
| 37406255 | 辰欣药业股份有限公司年报信息披露重大差错责任追究管理制度(2025年10月) | 2025-10-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cisen Pharmaceutical Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57632/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57632 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57632 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57632 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57632}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cisen Pharmaceutical Co.,Ltd. (id: 57632)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.